393 related articles for article (PubMed ID: 17485651)
1. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy.
Tackenberg B; Lünemann JD; Steinbrecher A; Rothenfusser-Korber E; Sailer M; Brück W; Schock S; Zschenderlein R; Zipp F; Sommer N
Neurology; 2007 May; 68(19):1622-9. PubMed ID: 17485651
[TBL] [Abstract][Full Text] [Related]
2. Atypical electrophysiologic findings in chronic inflammatory demyelinating polyneuropathy (CIDP)--diagnosis confirmed by nerve biopsy.
Boukhris S; Magy L; Kabore R; Mabrouk T; Li Y; Sindou P; Tabaraud F; Vallat JM
Neurophysiol Clin; 2004 Apr; 34(2):71-9. PubMed ID: 15130553
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis.
Rajabally YA; Jacob S
Muscle Nerve; 2008 Jul; 38(1):855-60. PubMed ID: 18508343
[TBL] [Abstract][Full Text] [Related]
4. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy.
Viala K; Maisonobe T; Stojkovic T; Koutlidis R; Ayrignac X; Musset L; Fournier E; Léger JM; Bouche P
J Peripher Nerv Syst; 2010 Mar; 15(1):50-6. PubMed ID: 20433605
[TBL] [Abstract][Full Text] [Related]
5. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
6. Sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy: are supportive pathologic criteria useful in diagnosis?
Kulkarni GB; Mahadevan A; Taly AB; Nalini A; Shankar SK
Neurol India; 2010; 58(4):542-8. PubMed ID: 20739789
[TBL] [Abstract][Full Text] [Related]
7. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
[TBL] [Abstract][Full Text] [Related]
8. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
Rentzos M; Anyfanti C; Kaponi A; Pandis D; Ioannou M; Vassilopoulos D
J Clin Neurosci; 2007 Mar; 14(3):229-35. PubMed ID: 17258131
[TBL] [Abstract][Full Text] [Related]
10. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
Caro XJ; Winter EF; Dumas AJ
Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with chronic inflammatory demyelinating polyneuropathy.
Van Doorn PA
Rev Neurol (Paris); 1996 May; 152(5):383-6. PubMed ID: 8881435
[TBL] [Abstract][Full Text] [Related]
14. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
15. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
16. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2010 Sep; 15(3):185-95. PubMed ID: 21040140
[TBL] [Abstract][Full Text] [Related]
17. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
18. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2006 Mar; 11(1):9-19. PubMed ID: 16519778
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of chronic inflammatory demyelinating polyneuropathy].
Lünemann JD; Prass K; Zschenderlein R
Fortschr Neurol Psychiatr; 2004 Dec; 72(12):672-8. PubMed ID: 15580532
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
Comi G; Quattrini A; Fazio R; Roveri L
Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
